Literature DB >> 3691977

The effect of indomethacin on cerebral blood-flow velocity in premature infants.

D H Evans1, M I Levene, L N Archer.   

Abstract

The prostaglandin synthetase inhibitor indomethacin is known to cause significant reduction in cerebral blood-flow (CBF) in certain newborn animals. The authors studied the effect of indomethacin on the CBF velocity of small premature infants, using duplex Doppler real-time ultrasound, and made a record of blood pressure (BP) and heart rate. Indomethacin was infused intravenously in five infants. Repeated measurements were made from the anterior cerebral artery for one hour after injection. There was a significant reduction in mean blood-flow velocity of 40 per cent two minutes after the injection, and it remained 35 per cent below pre-dose levels for at least one hour. There was a simultaneous rise of 15 per cent in systemic BP by one minute after injection. It is argued that these these changes represent a significant reduction in CBF, and this may increase the likelihood of border-zone ischaemic infarction in ill premature infants with pre-existing critical cerebral perfusion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691977     DOI: 10.1111/j.1469-8749.1987.tb08823.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  11 in total

Review 1.  Patent ductus arteriousus in the premature neonate: current concepts in pharmacological management.

Authors:  C Hammerman; M Kaplan
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome. Report of a Joint Working Group of the British Association of Perinatal Medicine and the Research Unit of the Royal College of Physicians.

Authors: 
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

3.  Effects of ethamsylate on cerebral blood flow velocity in premature babies.

Authors:  J M Rennie; P K Lam
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

4.  Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity.

Authors:  J M Rennie; R W Cooke
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

5.  Drug induced closure of patent ductus arteriosus.

Authors:  N Archer
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 6.  Patent ductus arteriosus in the newborn.

Authors:  N Archer
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

7.  Cerebral autoregulation in neonates with a hemodynamically significant patent ductus arteriosus.

Authors:  Valerie Y Chock; Chandra Ramamoorthy; Krisa P Van Meurs
Journal:  J Pediatr       Date:  2012-01-09       Impact factor: 4.406

8.  Effect of infusion rate of indomethacin on cerebrovascular responses in preterm neonates.

Authors:  P Colditz; D Murphy; P Rolfe; A R Wilkinson
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

9.  Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants.

Authors:  N C Austin; P W Pairaudeau; T K Hames; M A Hall
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 10.  Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants.

Authors:  A S Görk; R A Ehrenkranz; M B Bracken
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.